⚕️ Educational information only — not medical advice. Read the full disclaimer

What Causes Arthritis? The Root Causes Explained

What causes arthritis? Conventional medicine has long sorted joint disease into tidy silos — osteoarthritis as "wear and tear," rheumatoid arthritis as an idiopathic autoimmune condition, gout as a purine problem. A growing body of holistic and functional-medicine literature argues these diagnoses may share deeper upstream drivers: gut dysbiosis and intestinal permeability, molecular mimicry from chronic infections, metabolic dysfunction, oxidative stress, nutrient gaps, and hormonal shifts. This page surveys those proposed root causes with honest evidence grading — much of it is emerging or contested rather than settled.

Important: This page is general educational information, not medical advice. Arthritis varies by person and type. Always consult a qualified healthcare professional before changing your diet, supplements, exercise, or medication, and never stop a prescribed medication without speaking to the prescribing physician.

Key takeaways

  • Holistic models reframe arthritis as a localized sign of systemic dysregulation rather than an isolated joint problem. Emerging
  • The gut-joint axis — dysbiosis, "leaky gut," and LPS endotoxemia driving IL-6 and TNF-α — is an active research area, but "leaky gut as a root cause" is not accepted by mainstream rheumatology. Contested
  • Molecular mimicry from infections (P. gingivalis, EBV; the Proteus theory is more contested) offers a plausible autoimmune trigger for RA. Emerging
  • Obesity and metabolic dysfunction worsen arthritis through inflammation, not just mechanical load — one of the better-supported links. Strong
  • Osteoarthritis becomes markedly more common in women around and after menopause Strong; falling estrogen as the cause is still being worked out Emerging.

The gut-joint axis Emerging Contested

Full guide: Leaky gut and arthritis — what the gut-joint research really shows, and why zonulin tests are unreliable.

The gastrointestinal tract harbors a vast microbial ecosystem that helps regulate systemic immunity. The "gut-joint axis" describes the proposed pathway by which an imbalance in that community — dysbiosis — may help orchestrate the pathogenesis of rheumatic disease.1 The foundational mechanism that proponents cite is a loss of intestinal barrier integrity, popularly called increased intestinal permeability or "leaky gut." We present this honestly: the gut microbiome's role is a genuine and fast-growing research field, but "leaky gut as a root cause of arthritis" remains contested and is not accepted as settled by mainstream rheumatology.

Mechanism: how the gut may reach the joint

In this model, a dysbiotic microbiome degrades the epithelial tight junctions lining the gut.1 The compromised barrier is said to permit translocation of microbial products — most notably lipopolysaccharide (LPS) from Gram-negative bacterial walls — into the circulation, producing low-grade endotoxemia. The innate immune system responds by releasing pro-inflammatory cytokines, particularly IL-6 and TNF-α, which circulate systemically and may act on synovial tissue, driving local joint inflammation.12 In one small study of knee osteoarthritis (25 patients), LPS levels in blood and synovial fluid were associated with activated synovial macrophages, osteophyte severity and knee symptoms — an association, not proof of cause.3

Dysbiosis is also proposed to disrupt immune homeostasis by shifting the balance between pro-inflammatory Th17 cells and immune-calming regulatory T cells (Tregs) toward Th17 dominance — a pattern described in RA, ankylosing spondylitis, and lupus.1 Specific microbial signatures have been reported: in stool sequencing of 114 people, Prevotella copri was strongly associated with new-onset, untreated rheumatoid arthritis, and it is emerging as a candidate biomarker.14

Gut-joint axis: driver → mechanism → joint effect
DriverProposed mechanismJoint effectEvidence
Microbiome dysbiosisDegrades epithelial tight junctions; raises permeabilitySets the stage for antigen translocationEmerging
LPS endotoxemiaCirculating endotoxin activates innate immunity, raising IL-6 / TNF-αCytokines deposit in synoviumEmerging
Th17 / Treg imbalanceShift toward Th17 dominanceAutoimmune-type synovial inflammationEmerging
Prevotella copriGut expansion correlated with RA onsetCandidate diagnostic biomarkerEmerging
"Leaky gut" as a root causeWhole-cascade causation claimProposed upstream trigger of joint diseaseContested

Because diet shapes the microbiome, proponents pair this section with dietary strategy — see foods that may worsen arthritis and the anti-inflammatory diet for the proposed gut-supportive counterpart.

Autoimmune triggers: molecular mimicry & chronic infections Emerging

Integrative literature places heavy emphasis on molecular mimicry as a primary inciting trigger for autoimmune arthritis. Mimicry occurs when a microbial, dietary, or environmental antigen shares a homologous amino-acid sequence with one of the host's own proteins. The antibodies and T-cells dispatched to neutralize the pathogen can then cross-react with human tissue, initiating an autoimmune attack.56

Mechanism: the "shared epitope" and Proteus mirabilis Contested

Proteus mirabilis, a common cause of urinary tract infection, carries the sequence ESRRAL in its hemolysin that closely mimics the RA-susceptibility motif EQKRAA — the "shared epitope" found in HLA-DRB1 alleles. Antibodies raised against Proteus may then cross-react with synovial tissue expressing those HLA markers, a proposed driver of RA pathogenesis.78 Note that this theory comes largely from a single research group, which describes Proteus as the main microbial culprit in RA; it has not been widely adopted in mainstream rheumatology.

A second example is Porphyromonas gingivalis, a keystone pathogen in severe periodontitis. It carries its own peptidylarginine deiminase (PPAD), an enzyme that converts arginine residues into citrulline; among the oral bacteria tested in one study, only P. gingivalis could citrullinate proteins, including human fibrinogen and α-enolase.9 Citrullinated proteins are the targets of the anti-CCP antibodies that are highly specific, predictive markers for RA. In a study of 2,807 people with RA, antibodies to a citrullinated P. gingivalis peptide were found in 11% versus 2% of controls, and gum-tissue B cells produced antibodies cross-reacting with human citrullinated peptides — supporting, though not proving, the idea that a gum infection could help trigger joint autoimmunity.10

Proposed infectious triggers and the mimicry mechanism
TriggerMechanismLinked marker / geneEvidence
Proteus mirabilisESRRAL motif mimics RA "shared epitope" EQKRAAHLA-DRB1Contested
P. gingivalis (periodontitis)PPAD citrullinates host proteins → neo-antigensanti-CCPEmerging
Enteric/urogenital bacteriaPost-infectious reactive arthritis, typically weeks laterHLA-B27Strong
Epstein-Barr virus (EBV)Viral mimicry implicated in initiating RA pathways—Emerging

Reactive arthritis (ReA) is the best-established example of infection-triggered arthritis Strong, appearing several weeks after a gastrointestinal or genitourinary infection. Classic bowel triggers include Salmonella, Shigella, Campylobacter, Yersinia and Clostridium difficile, while Chlamydia trachomatis is the main sexually transmitted trigger. Most people with these infections never develop ReA; carrying HLA-B27 raises the risk of severe or chronic disease, but HLA-B27-negative people can develop it too.11 Viral triggers — notably Epstein-Barr virus (EBV) — are also implicated: people with RA carry high anti-EBV antibody titres and a roughly 10-fold higher EBV load in blood, and EBV mimicry of human proteins has been proposed as one way the virus could help initiate autoimmunity.1213

Systemic inflammation & metabolic dysfunction Strong (obesity) Emerging (mechanisms)

While conventional medicine frames osteoarthritis as mechanical, a substantial body of evidence positions it — alongside gout — as partly metabolic. Researchers have proposed "metabolic osteoarthritis" as a distinct subtype linked to metabolic syndrome, with hyperglycemia, dyslipidemia, adipokines and low-grade systemic inflammation all implicated in cartilage damage.14 Obesity is associated with osteoarthritis even in the non-weight-bearing joints of the hand (approximate risk ratio 1.9), which points to systemic effects beyond mechanical load.15 The link between obesity, metabolic syndrome, and arthritis is one of the better-established findings in this guide. Holistic practitioners further cite the Western diet, psychological stress, inactivity and sleep loss as upstream drivers of this inflammatory milieu; those specific links are plausible but less directly studied.

AGEsCross-link collagen, stiffening cartilage
RAGEReceptor that switches on cartilage-degrading enzymes
3+Pro-inflammatory adipokines from visceral fat

Mechanism: hyperglycemia, AGEs and the RAGE receptor

Non-enzymatic glycation of long-lived cartilage collagen yields Advanced Glycation End-products (AGEs), which accumulate with age; chronic hyperglycemia is proposed to speed this up.14 In laboratory experiments on human cartilage, raising AGE cross-links made the collagen network markedly stiffer (cartilage deformation under load fell by up to 40%) — a putative reason ageing cartilage resists damage less well.16 AGEs also bind the RAGE receptor on chondrocytes and synovial fibroblasts; in cell studies this increased proteoglycan release and production of the cartilage-degrading enzyme MMP-1, effects blocked by an anti-RAGE antibody.17

Crucially, obesity contributes to arthritis not only through mechanical load but through the endocrine activity of adipose tissue, which acts as an active organ secreting adipokines. Leptin, resistin, and visfatin are considered pro-inflammatory,1819 and leptin, resistin and adiponectin have all been detected in synovial fluid from OA and RA joints.18 Adiponectin is often described as anti-inflammatory,19 but in RA it is found at higher levels in serum and synovial fluid and may act pro-inflammatorily in the joint — so "low adiponectin" is not a simple explanation.20 Elevated serum uric acid and hs-CRP often accompany this metabolic picture. Dietary contributors to this pathway — refined sugar, high-fructose corn syrup, and AGE-rich cooking — are covered on foods that worsen arthritis.

Metabolic drivers of joint damage
DriverMechanismJoint effectEvidence
Insulin resistance / hyperglycemiaGenerates AGEs; systemic inflammationCartilage stiffening, accelerated catabolismEmerging
AGEs / RAGE signalingCollagen cross-linking + catabolic enzyme releaseStiffer matrix, cartilage breakdownEmerging
Obesity (overall)Associated with OA, including non-weight-bearing hand jointsHigher OA risk beyond mechanical loadStrong
Adipokines (leptin, resistin, visfatin)Pro-inflammatory adipokines found in synovial fluidJoint inflammationEmerging
AdiponectinAnti-inflammatory in some settings, possibly pro-inflammatory in RA jointsUnclearContested

Oxidative stress at the cellular level Emerging

At the cellular level, joint disease may be perpetuated by severe oxidative stress. Reactive oxygen species (ROS) and nitric oxide (NO) — volatile molecules produced during metabolic dysfunction and immune activation — can overwhelm the joint's antioxidant defenses.21

Mechanism: ROS, chondrocyte apoptosis and MMPs

In osteoarthritis, excess ROS are implicated in chondrocyte (the cells that maintain cartilage) senescence and apoptosis (programmed cell death), in disturbed matrix synthesis and breakdown, and in synovial inflammation and subchondral bone changes.21 Breakdown is carried out largely by matrix metalloproteinases (MMPs), enzymes that degrade collagen and proteoglycans and are upregulated in both OA and RA.22

Because this pathway is downstream of inflammation and metabolic stress, the same markers tracked elsewhere in this guide — hs-CRP and IL-6 — tend to move with it.

Nutrient deficiencies & cartilage degradation Emerging

Maintaining and repairing the cartilage matrix requires a continuous supply of specific micronutrients. Proponents argue that deficiencies in these building blocks can stall chondrocyte repair and accelerate degeneration.

Mechanism: Vitamin K, MGP and cartilage calcification

Vitamin K (including K2, menaquinone) is a cofactor for γ-glutamyl carboxylase, which activates Matrix Gla Protein (MGP) — an inhibitor of cartilage calcification — and other Gla proteins. Without adequate vitamin K, MGP stays uncarboxylated and less active, and cartilage calcification, which plays a role in osteoarthritis, may proceed more easily. Observational studies generally link sufficient vitamin K status with lower OA risk, but clinical-trial evidence is limited.23 Synovial-fluid levels of MGP and Gla-rich protein differ between OA and non-OA knees, making them candidate biomarkers.24

Nutrients implicated in cartilage maintenance
NutrientProposed roleDeficiency effect
Vitamin K (K1/K2)Carboxylates MGP to block cartilage calcificationPathological micro-calcification of cartilage
Vitamin DImmune regulation; downregulates MMPsUninhibited MMP expression, autoimmune reactivity
MagnesiumRequired to convert vitamin D to active formImpaired vitamin D activation
Vitamin C + collagen precursorsCollagen synthesis (with copper, glycine, proline)Weakened extracellular matrix
Omega-3 (EPA/DHA)Precursors for pro-resolving mediators (SPMs)Failure to resolve synovial inflammation

Omega-3 fatty acids (EPA and DHA) are highlighted as precursors for specialized pro-resolving mediators (SPMs) that help actively terminate inflammation in synovial fluid. These dietary levers are explored further in the anti-inflammatory diet. Supplement decisions belong with your physician, and high-dose supplements should not be started without professional guidance.

Plausible mechanisms have not always translated into treatment benefits. Correcting a measured vitamin D deficiency is well supported for bone health Strong, but two-year randomized trials in knee osteoarthritis found that vitamin D supplements did not reduce pain or slow cartilage loss, and the ACR conditionally recommends against vitamin D and fish oil as OA treatments Contested. Details and sources are on the osteoarthritis page and the supplements guide.

Dietary & supplement note: Statements here about nutrients and dietary supplements have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease.

Hormonal imbalances Strong (postmenopausal OA association) Emerging (estrogen mechanism, cortisol, thyroid) Contested (HRT as OA treatment)

Endocrine changes may exert an independent influence on joint disease. The well-documented rise in osteoarthritis among women around and after menopause is one of the more firmly supported patterns in this guide. Falling estrogen is the leading explanation, but that causal link rests mainly on laboratory and animal work, and human trials of hormone therapy for OA have not given clear answers. No guideline recommends hormone therapy to treat OA.2526 See estrogen and menopause in osteoarthritis.

Estrogen receptors (ERα and the G protein-coupled GPER) are heavily expressed in cartilage and synovium. Estrogen appears to maintain cartilage homeostasis by inhibiting chondrocyte apoptosis and suppressing cartilage-destroying inflammatory factors.2527 A 2026 systematic review found significantly greater cartilage degeneration in ovariectomized animals than in controls, but in women the pooled results showed only non-significant trends toward more cartilage loss, and hormone replacement effects were inconsistent.28

Mechanism: chronic cortisol and subchondral bone

Cortisol, the HPA-axis stress hormone, plays a dual role. Acute release is anti-inflammatory, but in viral-challenge studies, long-term stress was linked to glucocorticoid receptor resistance — a reduced ability of cortisol to switch off inflammation.29 Sustained high glucocorticoid levels, documented most clearly with long-term steroid medication, suppress bone-building osteoblasts and increase bone resorption.30 Some practitioners extend this to argue that everyday psychological stress weakens the subchondral bone and accelerates osteoarthritis; that chain has not been demonstrated in people. Contested (If you take prescribed steroids, do not stop or change them without your doctor — stopping abruptly can be dangerous.)

Thyroid imbalance can also affect the joints: in a clinical study of people with severe hypothyroidism, most had viscous, non-inflammatory joint effusions, generalized stiffness was universal, and many had calcium pyrophosphate deposits in cartilage (chondrocalcinosis) — making hypothyroidism a treatable cause to rule out.31 Stress and sleep, which drive the cortisol pathway, are covered alongside other environmental triggers.

Frequently asked questions

What causes arthritis, in plain terms?

Holistic literature points to upstream drivers — gut dysbiosis and intestinal permeability, molecular mimicry from infections, metabolic dysfunction, oxidative stress, nutrient gaps, and hormonal change — rather than a single cause. Many of these mechanisms are emerging or contested, not settled fact. This is educational information, not a diagnosis; talk to a qualified physician about your case.

Is osteoarthritis just "wear and tear"?

That has been the conventional framing, but emerging research suggests systemic inflammation and metabolic factors — including AGEs and adipokines from visceral fat — also contribute. The obesity–arthritis link in particular is well supported.

Can my gut really affect my joints?

Some research suggests the gut microbiome and intestinal barrier may influence the systemic inflammation linked to joint disease (the gut-joint axis). The evidence is promising but emerging, and the stronger "leaky gut as a root cause" claim is contested. Individual results vary.

Does menopause affect arthritis?

Osteoarthritis becomes markedly more common in women around and after menopause. Declining estrogen is the leading explanation, supported mainly by animal studies; human evidence is less clear, and no guideline recommends hormone therapy to treat OA. Hormone-related decisions belong with your physician.

References

  1. Şahin N, Salbaş E. The Gut-Joint Connection: Microbiome's Role in Rheumatic Disease. Arch Rheumatol. 2025. pubmed.ncbi.nlm.nih.gov/41589431/
  2. Zhong S, et al. The brain-gut-joint axis in arthritis: crosstalk, treatment, and future perspectives. J Orthop Translat. 2026. pubmed.ncbi.nlm.nih.gov/41836576/
  3. Huang ZY, Stabler T, Pei FX, Kraus VB. Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation. Osteoarthritis Cartilage. 2016. pubmed.ncbi.nlm.nih.gov/27216281/
  4. Scher JU, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife. 2013. pubmed.ncbi.nlm.nih.gov/24192039/
  5. Fehringer M, Vogl T. Molecular mimicry in the pathogenesis of autoimmune rheumatic diseases. J Transl Autoimmun. 2025. pubmed.ncbi.nlm.nih.gov/39877080/
  6. Vojdani A. A Potential Link between Environmental Triggers and Autoimmunity. Autoimmune Dis. 2014. pubmed.ncbi.nlm.nih.gov/24688790/
  7. Rashid T, Ebringer A, Wilson C. The link between Proteus mirabilis, environmental factors and autoantibodies in rheumatoid arthritis. Clin Exp Rheumatol. 2017. pubmed.ncbi.nlm.nih.gov/28516867/
  8. Tiwana H, et al. Cross-reactivity between the rheumatoid arthritis-associated motif EQKRAA and structurally related sequences found in Proteus mirabilis. Infect Immun. 1999. pubmed.ncbi.nlm.nih.gov/10338479/
  9. Wegner N, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 2010. pubmed.ncbi.nlm.nih.gov/20506214/
  10. Sherina N, et al. Antibodies to a Citrullinated Porphyromonas gingivalis Epitope Are Increased in Early Rheumatoid Arthritis, and Can Be Produced by Gingival Tissue B Cells. Front Immunol. 2022. pubmed.ncbi.nlm.nih.gov/35514991/
  11. Reactive Arthritis — American College of Rheumatology (patient fact sheet). rheumatology.org/patients/reactive-arthritis
  12. Balandraud N, Roudier J. Epstein-Barr virus and rheumatoid arthritis. Joint Bone Spine. 2018. pubmed.ncbi.nlm.nih.gov/28499895/
  13. Munir A, et al. The Role of Epstein-Barr Virus Molecular Mimicry in Various Autoimmune Diseases. Scand J Immunol. 2025. pubmed.ncbi.nlm.nih.gov/40155782/
  14. Zhuo Q, Yang W, Chen J, Wang Y. Metabolic syndrome meets osteoarthritis. Nat Rev Rheumatol. 2012. pubmed.ncbi.nlm.nih.gov/22907293/
  15. Yusuf E, et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann Rheum Dis. 2010. pubmed.ncbi.nlm.nih.gov/19487215/
  16. Verzijl N, et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage. Arthritis Rheum. 2002. pubmed.ncbi.nlm.nih.gov/11822407/
  17. Steenvoorden MM, et al. Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum. 2006. pubmed.ncbi.nlm.nih.gov/16385542/
  18. Toussirot E, Streit G, Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem. 2007. pubmed.ncbi.nlm.nih.gov/17456023/
  19. Toussirot E. Mini-Review: The Contribution of Adipokines to Joint Inflammation in Inflammatory Rheumatic Diseases. Front Endocrinol (Lausanne). 2020. pubmed.ncbi.nlm.nih.gov/33424772/
  20. Szumilas K, et al. Role of Adiponectin in the Pathogenesis of Rheumatoid Arthritis. Int J Mol Sci. 2020. pubmed.ncbi.nlm.nih.gov/33158216/
  21. Lepetsos P, Papavassiliou AG. ROS/oxidative stress signaling in osteoarthritis. Biochim Biophys Acta. 2016. pubmed.ncbi.nlm.nih.gov/26769361/
  22. Rose BJ, Kooyman DL. A Tale of Two Joints: The Role of Matrix Metalloproteases in Cartilage Biology. Dis Markers. 2016. pubmed.ncbi.nlm.nih.gov/27478294/
  23. Chin KY. The Relationship between Vitamin K and Osteoarthritis: A Review of Current Evidence. Nutrients. 2020. pubmed.ncbi.nlm.nih.gov/32344816/
  24. Kurtulus B, et al. Gla-Rich Protein (GRP) and Matrix Gla Protein (MGP) as Possible New Players in the Molecular Mechanism of Osteoarthritis. J Clin Med. 2024. pubmed.ncbi.nlm.nih.gov/39274372/
  25. Atasoy-Zeybek A, et al. The intersection of aging and estrogen in osteoarthritis. NPJ Womens Health. 2025. pubmed.ncbi.nlm.nih.gov/40017990/
  26. Roman-Blas JA, et al. Osteoarthritis associated with estrogen deficiency. Arthritis Res Ther. 2009. pubmed.ncbi.nlm.nih.gov/19804619/
  27. Zhao H, Yu F, Wu W. The Mechanism by Which Estrogen Level Affects Knee Osteoarthritis Pain in Perimenopause and Non-Pharmacological Measures. Int J Mol Sci. 2025. pubmed.ncbi.nlm.nih.gov/40141035/
  28. Tehalia MK, et al. Estrogen Deficiency in Menopause: A Major Contributor to Cartilage Degeneration and Osteoarthritis: A Systematic Review and Meta-Analysis. J Menopausal Med. 2026. pubmed.ncbi.nlm.nih.gov/42045087/
  29. Cohen S, et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci U S A. 2012. pubmed.ncbi.nlm.nih.gov/22474371/
  30. Canalis E, et al. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007. pubmed.ncbi.nlm.nih.gov/17566815/
  31. Dorwart BB, Schumacher HR. Joint effusions, chondrocalcinosis and other rheumatic manifestations in hypothyroidism: a clinicopathologic study. Am J Med. 1975. pubmed.ncbi.nlm.nih.gov/171946/